News
Lockheed Martin Corp. (NYSE: LMT) recently announced that its board of directors has authorized a third-quarter, 2025 ...
Following the U.S. House and Senate completing their work on the One Big Beautiful Bill Act — enacting much of President ...
Lockheed Martin Corp. (NYSE: LMT) has been awarded a $78.4 million modification to a previously awarded contract to exercise the option and provide ...
TissueCypher is a laboratory test that can help predict the risk of developing esophageal cancer in patients diagnosed with Barrett’s esophagus (BE).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results